RESEARCH TRIANGLE PARK, N.C., June 3, 2014 /PRNewswire/ -- Marken announced today that they will host an industry workshop to discuss the emerging direct to patient clinical trial market, and that they have forged a global co-marketing relationship with GlobalCare Clinical Trials, Ltd, the leading global provider of ambulant health care services for clinical trials.
Marken's Direct to Patient (DTP) Home Delivery Service provides delivery of clinical trial materials directly to a patient's home as well as retrieval of biological specimens for testing, with quality guaranteed through full temperature monitoring (when required) from pick up to delivery. Now, Marken's DTP services can be combined with GlobalCare Clinical Trials' network of clinicians to offer a comprehensive home-based solution for clinical trials. GlobalCare Clinical Trials conducts study visits at patients' homes or other convenient locations via its global network of traveling clinicians to facilitate trials for a variety of indications and all age groups. The combination of Marken and GlobalCare provides clients with a comprehensive solution.
Patient recruitment and retention is one of the biggest challenges in clinical trials. Bringing the trial to the patient's home provides advantages from both compliance and patient retention perspectives. Patients unable to travel to the investigator site for each visit may instead conveniently receive treatment, assessments or have bloods drawn at home for selected protocol visits. Patients who face travel challenges due to remote location or current health condition may find this option a compelling reason to participate and remain enrolled in a clinical trial.
The industry realizes the clear need to create a more patient-centric approach that will improve willingness and ability for patients to participate in clinical trials. Leslie Chaney, Marken's Global Director for Preclinical and Direct to Patient Services said, "Marken and GlobalCare are a natural collaboration to provide seamless patient care according to the protocol requirements at their homes or any other location." Gail Adinamis, Chief Executive Officer for GlobalCare agreed, adding "Our collaboration creates synergies to benefit the patients and investigator sites, and also creates cost efficiencies for the trial sponsors."
Marken and GlobalCare will co-host an industry workshop on the Direct to Patient topic. Case studies, solutions, and patient-centric models addressing geography, demographics, and drug storage conditions will be presented.
The workshop will take place at the Hyatt Regency Princeton (New Jersey) on Thursday, July 17th from 9am - noon. To reserve your place, email RSVP.email@example.com
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies.
GlobalCare Clinical Trials, Ltd is a global niche service provider offering a patient-centric service model that provides selected clinical study visits in the home or alternate setting. Services are provided in over 35 countries, through an extensive network of multilingual Country Coordinators and local highly skilled ambulant nurses. For more information, please visit www.globalcarect.com.